PA
AKBA icon

Perceptive Advisors’s Akebia Therapeutics AKBA Stock Holding History

Perceptive Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-52,724
Closed -$716K – 128
2020
Q2 		$716K Buy
+52,724
New +$545K 0.01% 116
2019
Q2 		– Sell
-1,703,440
Closed -$14M – 108
2019
Q1 		$14M Hold
1,703,440
– – 0.39% 49
2018
Q4 		$9.18M Sell
1,703,440
-746,081
-30% -$5.84M 0.35% 54
2018
Q3 		$21.6M Buy
2,449,521
+234,121
+11% +$2.09M 0.58% 41
2018
Q2 		$22.1M Sell
2,215,400
-247,000
-10% -$2.47M 0.58% 46
2018
Q1 		$23.5M Buy
2,462,400
+475,000
+24% +$6.64M 0.66% 37
2017
Q4 		$29.6M Buy
1,987,400
+357,400
+22% +$5.93M 0.98% 26
2017
Q3 		$32.1M Buy
1,630,000
+530,000
+48% +$8.15M 1.22% 18
2017
Q2 		$15.8M Buy
1,100,000
+1,050,376
+2,117% +$13.3M 0.8% 36
2017
Q1 		$457K Sell
49,624
-487,632
-91% -$4.76M 0.03% 124
2016
Q4 		$5.59M Sell
537,256
-271,840
-34% -$2.34M 0.4% 57
2016
Q3 		$7.29M Sell
809,096
-84,504
-9% -$718K 0.47% 52
2016
Q2 		$6.68M Buy
893,600
+28,600
+3% +$250K 0.46% 49
2016
Q1 		$7.79M Buy
865,000
+605,000
+233% +$4.91M 0.68% 37
2015
Q4 		$3.36M Hold
260,000
– – 0.25% 64
2015
Q3 		$2.51M Buy
+260,000
New +$2.39M 0.2% 74

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors's AKBA Position: Q3 2020 in Review

Perceptive Advisors sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 52,724 shares — an estimated $716K sold.

Perceptive Advisors first reported a position in AKBA in Q3 2015 and held it in 16 quarters. The position peaked at $32.1M in Q3 2017. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

  • Perceptive Advisors reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Perceptive Advisors sold 52,724 Akebia Therapeutics shares in Q3 2020, an estimated $716K.
  • Perceptive Advisors first reported a position in Akebia Therapeutics in Q3 2015 and held it in 16 quarters.
  • Perceptive Advisors's Akebia Therapeutics position peaked at $32.1M in Q3 2017.
  • 164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.